| Recruiting | Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI NCT04954599 | Maastricht University Medical Center | Phase 1 / Phase 2 |
| Terminated | A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Soli NCT04842630 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Suspended | TR1801-ADC in Patients With Tumors That Express c-Met NCT03859752 | Open Innovation Partners, Inc. | Phase 1 |
| Active Not Recruiting | RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Whic NCT02112565 | City of Hope Medical Center | Phase 1 |
| Completed | A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or M NCT02869295 | Nektar Therapeutics | Phase 1 / Phase 2 |
| Active Not Recruiting | Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer NCT02293954 | City of Hope Medical Center | N/A |
| Terminated | Quantitative MRI in Assessing Disease in Patients With Brain Tumors NCT02269111 | Vanderbilt-Ingram Cancer Center | N/A |
| Completed | S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstructi NCT02270450 | SWOG Cancer Research Network | N/A |
| Withdrawn | Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Tr NCT02048943 | Roswell Park Cancer Institute | Phase 1 |
| Completed | APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Me NCT02166255 | Wake Forest University Health Sciences | Phase 1 |
| Completed | Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patien NCT01828775 | City of Hope Medical Center | N/A |
| Completed | VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors NCT02146222 | University of Wisconsin, Madison | Phase 1 |
| Completed | Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patien NCT02116530 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Withdrawn | Icotinib Hydrochloride in Treating Patients With Advanced Cancers NCT02033148 | Roswell Park Cancer Institute | Phase 1 |
| Recruiting | Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors NCT02215928 | Stanford University | — |
| Terminated | Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastati NCT02070406 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Completed | Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell L NCT02194049 | University of California, Davis | Phase 1 |
| Terminated | Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema NCT01893879 | Stanford University | N/A |
| Completed | PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Ca NCT02088775 | Fox Chase Cancer Center | N/A |
| Completed | Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot B NCT02013492 | William Carson | EARLY_Phase 1 |
| Terminated | Communication Training in Promoting Employment Retention Among Cancer Patients NCT02895490 | Virginia Commonwealth University | N/A |
| Completed | Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy NCT01898130 | Northwestern University | Phase 2 |
| Completed | Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiothera NCT02153151 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | — |
| Completed | Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors NCT01957995 | University of Southern California | Phase 1 |
| Terminated | Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection NCT01249443 | AIDS Malignancy Consortium | Phase 1 |
| Completed | MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma NCT01748721 | Morphotek | Phase 1 |
| Completed | FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents NCT02055586 | Case Comprehensive Cancer Center | — |
| Completed | Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer NCT01924260 | Edward Kim | Phase 1 |
| Withdrawn | Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung Cance NCT02126527 | Mayo Clinic | Phase 1 |
| Completed | Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer NCT01923337 | University of California, Davis | Phase 1 |
| Completed | Quality of Life in Caregivers of Hospitalized Older Patients With Cancer NCT01866969 | City of Hope Medical Center | N/A |
| Completed | PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast C NCT01892540 | Case Comprehensive Cancer Center | N/A |
| Terminated | Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or NCT01835184 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | Copenhagen Prospective Personalized Oncology (CoPPO) NCT02290522 | Ulrik Lassen | N/A |
| Withdrawn | Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole NCT02277561 | Albert Einstein College of Medicine | N/A |
| Completed | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis NCT01806675 | Sanjiv Sam Gambhir | Phase 1 / Phase 2 |
| Unknown | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors NCT01764087 | Hanmi Pharmaceutical Company Limited | Phase 1 / Phase 2 |
| Completed | Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors NCT01713972 | Manisha Shah | Phase 1 |
| Withdrawn | Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemothe NCT01644097 | Stanford University | Phase 2 |
| Completed | Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors NCT01217450 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis NCT01705548 | Emory University | N/A |
| Terminated | Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors NCT01642342 | University of Southern California | Phase 1 |
| Terminated | Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Ther NCT01705106 | University of Chicago | Phase 1 |
| Completed | A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03) NCT01566279 | UMC Utrecht | N/A |
| Terminated | A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors NCT01631279 | Proacta, Incorporated | Phase 1 / Phase 2 |
| Completed | Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials NCT01612598 | City of Hope Medical Center | N/A |
| Completed | Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery NCT01791088 | University of Chicago | Phase 1 |
| Completed | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers NCT01560325 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, C NCT01540253 | Roswell Park Cancer Institute | Phase 1 |
| Terminated | Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors NCT01573780 | Roswell Park Cancer Institute | Phase 1 |
| Completed | Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastati NCT01497392 | Roswell Park Cancer Institute | Phase 1 |
| Completed | Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Can NCT01537107 | Mayo Clinic | Phase 1 |
| Terminated | Positron Emission Tomography/Magnetic Resonance Imaging in Patients NCT01557881 | Case Comprehensive Cancer Center | N/A |
| Completed | Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surg NCT01527136 | Roswell Park Cancer Institute | Phase 1 |
| Completed | 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With R NCT01470365 | Fox Chase Cancer Center | Phase 1 |
| Completed | Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy NCT01506440 | Wake Forest University Health Sciences | — |
| Completed | An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have NCT01418677 | Eisai Inc. | Phase 1 |
| Terminated | Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies NCT01602627 | Dale Shepard, MD, PhD | Phase 1 |
| Terminated | Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases NCT01417403 | Virginia Commonwealth University | Phase 1 |
| Completed | ABC294640 in Treating Patients With Advanced Solid Tumors NCT01488513 | RedHill Biopharma Limited | Phase 1 |
| Completed | Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients NCT01337765 | Pfizer | Phase 1 |
| Completed | Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Hav NCT01372774 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Withdrawn | Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer NCT01383668 | Mayo Clinic | Phase 1 |
| Terminated | NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors NCT01324115 | Cancer Research UK | Phase 1 |
| Completed | Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy NCT01198145 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases NCT01227954 | Radiation Therapy Oncology Group | Phase 2 |
| Terminated | Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients Wit NCT01234922 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases NCT01586104 | Ann & Robert H Lurie Children's Hospital of Chicago | N/A |
| Unknown | Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT) NCT01032278 | M.D. Anderson Cancer Center | N/A |
| Completed | Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tu NCT01245205 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Reflexology or Aromatherapy Massage in Relieving Symptoms in Patients With Cancer NCT01217424 | Royal Marsden NHS Foundation Trust | N/A |
| Completed | Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma NCT01169532 | Fox Chase Cancer Center | Phase 1 |
| Completed | Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies NCT01243359 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors NCT01233505 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors NCT01407562 | Rutgers, The State University of New Jersey | Phase 1 |
| Completed | Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors NCT01206465 | University of Nebraska | Phase 1 |
| Completed | 1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors NCT01191216 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanc NCT01198184 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain NCT00930332 | NCIC Clinical Trials Group | Phase 1 |
| Completed | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors NCT01158274 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tum NCT01145456 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory NCT01159301 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor NCT01096381 | Vanderbilt-Ingram Cancer Center | — |
| Completed | S0916, MLN1202 in Treating Patients With Bone Metastases NCT01015560 | SWOG Cancer Research Network | Phase 2 |
| Completed | Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors NCT01118611 | Cancer Research UK | Phase 1 |
| Completed | Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies NCT01096355 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer NCT01042535 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 / Phase 2 |
| Completed | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers NCT01028859 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Terminated | Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel NCT01096407 | Vanderbilt-Ingram Cancer Center | — |
| Terminated | Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases NCT01018836 | Rutgers, The State University of New Jersey | Phase 1 |
| Terminated | Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors NCT01098643 | Vanderbilt University | N/A |
| Completed | Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer NCT00956813 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Unknown | Screening Tools to Predict Treatment Outcome in Older Cancer Patients Who Are Undergoing Treatment NCT01005693 | Ziekenhuis Netwerk Antwerpen (ZNA) | N/A |
| Completed | Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis NCT00956254 | INSYS Therapeutics Inc | Phase 3 |
| Completed | Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors NCT00878904 | University of California, San Francisco | Phase 1 |
| Recruiting | Registry of Older Patients With Cancer NCT01137825 | UNC Lineberger Comprehensive Cancer Center | — |
| Completed | Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refra NCT00949949 | Mayo Clinic | Phase 1 |
| Completed | Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy NCT00924651 | Gary Morrow | N/A |
| Recruiting | 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer NCT00935090 | Barbara Ann Karmanos Cancer Institute | — |
| Recruiting | Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants NCT00992303 | University of Texas Southwestern Medical Center | — |
| Completed | Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Ca NCT00981162 | Roswell Park Cancer Institute | Phase 1 |
| Terminated | Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors NCT00804310 | University of California, Davis | Phase 1 |
| Completed | Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy NCT00890747 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer NCT01008904 | Virginia Commonwealth University | Phase 2 |
| Completed | FAU in Treating Patients With Advanced Solid Tumors or Lymphoma NCT00769288 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be NCT00891072 | National Cancer Institute (NCI) | Phase 1 |
| Completed | SORAVE - Sorafenib and Everolimus in Solid Tumors NCT00933777 | University of Cologne | Phase 1 |
| Completed | White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer NCT00936728 | Academic and Community Cancer Research United | N/A |
| Completed | Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced NCT00849550 | Herbert Hurwitz | Phase 1 |
| Completed | Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemother NCT00952848 | Virginia Commonwealth University | Phase 2 |
| Completed | Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigu NCT01019187 | Abramson Cancer Center at Penn Medicine | Phase 2 |
| Completed | Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors NCT00914147 | Barbara Ann Karmanos Cancer Institute | N/A |
| Completed | Depression Screening in Patients Undergoing Radiation Therapy For Cancer NCT00951184 | Radiation Therapy Oncology Group | — |
| Completed | Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy NCT00880191 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumor NCT00701298 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases NCT00910039 | Case Comprehensive Cancer Center | Phase 2 |
| Terminated | Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer NCT00726830 | M.D. Anderson Cancer Center | N/A |
| Completed | Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Ca NCT00964275 | University Hospital, Brest | N/A |
| Terminated | Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Soli NCT00807755 | University of California, Davis | Phase 1 |
| Completed | Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors NCT00837928 | John Grecula | Phase 1 |
| Completed | Acute Pain Caused by Paclitaxel in Patients With Cancer NCT00860041 | Alliance for Clinical Trials in Oncology | — |
| Completed | Stereotactic Body Radiation Therapy and Vertebroplasty in Treating Patients With Localized Spinal Metastasis NCT00855803 | University of Texas Southwestern Medical Center | Phase 2 |
| Completed | Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Canc NCT00825201 | City of Hope Medical Center | Phase 1 |
| Completed | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer NCT00823524 | Asan Medical Center | Phase 1 / Phase 2 |
| Completed | Sorafenib in Treating Patients With Advanced Malignant Solid Tumors NCT00810394 | University of California, Davis | Phase 2 |
| Completed | S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases NCT00874211 | SWOG Cancer Research Network | — |
| Completed | Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors NCT00884676 | Jaime Merchan | Phase 1 |
| Completed | Acupressure Wristbands or Standard Care in Controlling Nausea Caused by Chemotherapy NCT00978185 | University of Manchester | Phase 3 |
| Completed | Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregive NCT00896792 | Mayo Clinic | EARLY_Phase 1 |
| Completed | Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded NCT00909831 | Abramson Cancer Center at Penn Medicine | Phase 1 |
| Completed | American Ginseng in Treating Patients With Fatigue Caused by Cancer NCT00719563 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Me NCT00972634 | Norwegian University of Science and Technology | — |
| Completed | Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors NCT00816335 | Ohio State University Comprehensive Cancer Center | EARLY_Phase 1 |
| Completed | Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on C NCT01015963 | Alliance for Clinical Trials in Oncology | — |
| Terminated | Stereotactic Radiosurgery in Treating Patients With Brain Metastases NCT00811655 | Duke University | Phase 2 |
| Withdrawn | S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors NCT00937417 | SWOG Cancer Research Network | Phase 1 |
| Withdrawn | Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain NCT00737191 | Mayo Clinic | N/A |
| Terminated | Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases NCT00814463 | Duke University | Phase 2 |
| Terminated | Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy NCT01031953 | OHSU Knight Cancer Institute | Phase 1 / Phase 2 |
| Completed | Dasatinib and Lapatinib Ditolsylate in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By NCT00662636 | Mayo Clinic | Phase 1 |
| Completed | Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Cli NCT00890435 | Children's Oncology Group | — |
| Completed | Prevention of Pegfilgrastim-Induced Bone Pain (PIBP) NCT00602420 | Gary Morrow | Phase 3 |
| Completed | Education Intervention in Encouraging Health Providers to Talk With Cancer Patients About the Use of Complemen NCT00608933 | M.D. Anderson Cancer Center | Phase 3 |
| Terminated | Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or NCT00704938 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Completed | Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00714181 | Abramson Cancer Center at Penn Medicine | Phase 1 |
| Terminated | Aerobic Exercise in Patients Receiving Chemotherapy for Cancer NCT00728429 | Wake Forest University Health Sciences | N/A |
| Withdrawn | Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers NCT00770419 | Rutgers, The State University of New Jersey | — |
| Completed | Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiv NCT00553059 | M.D. Anderson Cancer Center | Phase 3 |
| Completed | Irinotecan in Treating Asian Patients With Solid Tumors NCT00731276 | National Cancer Centre, Singapore | Phase 1 |
| Completed | Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer NCT00489411 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clin NCT00750009 | Case Comprehensive Cancer Center | Phase 3 |
| Completed | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma NCT00734890 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma NCT00659568 | London Health Sciences Centre | Phase 1 |
| Completed | Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases NCT00566852 | Radiation Therapy Oncology Group | Phase 3 |
| Completed | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did N NCT00610948 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Completed | Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in NCT00516503 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Methylphenidate in Treating Patients With Fatigue Caused by Cancer NCT00376675 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases NCT00540969 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Withdrawn | Positive Changes in Quality of Life of Older Cancer Patients and Their Caregivers NCT00769249 | Case Comprehensive Cancer Center | — |
| Completed | Kidney and Blood Pressure Changes in Patients Receiving Bevacizumab, Aflibercept, Sunitinib, or Cediranib for NCT00691730 | University Health Network, Toronto | — |
| Completed | PR104 and G-CSF in Treating Patients With Solid Tumors NCT00616213 | Proacta, Incorporated | Phase 1 |
| Completed | Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer NCT00769951 | Case Comprehensive Cancer Center | — |
| Terminated | GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy NCT01147029 | Cancer Research UK | Phase 1 |
| Withdrawn | Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery NCT00601614 | Mayo Clinic | Phase 1 |
| Completed | Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer NCT00712712 | Institut Bergonié | Phase 2 |
| Terminated | Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors NCT00875004 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Completed | Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression NCT00727584 | Cancer Research UK | N/A |
| Terminated | Studying Fentanyl in Patients With Cancer NCT00899951 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Suspended | Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors NCT00695032 | Institut Claudius Regaud | N/A |
| Completed | 1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed B NCT00567931 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Pa NCT00471445 | Gary Morrow | Phase 3 |
| Unknown | Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer NCT00898794 | Kantonsspital Graubuenden | — |
| Completed | Spinal Cord Compression Re-Treat Study NCT00974168 | Cancer Trials Ireland | Phase 2 |
| Completed | KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment NCT00646139 | Roswell Park Cancer Institute | Phase 1 |
| Terminated | Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain NCT00550654 | National Institutes of Health Clinical Center (CC) | Phase 2 |
| Completed | G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy NCT00770172 | Centre Francois Baclesse | Phase 3 |
| Completed | SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors NCT00504296 | NCIC Clinical Trials Group | Phase 1 |
| Unknown | Screening to Predict Weight Loss in Patients With Cancer NCT00710632 | Queen's Medical Center | N/A |
| Completed | R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extens NCT00544596 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metast NCT00573690 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Completed | Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors NCT00892385 | Case Comprehensive Cancer Center | Phase 1 |
| Completed | Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lun NCT00521144 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Terminated | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer NCT01212887 | Cancer Research UK | Phase 1 |
| Completed | Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma NCT00589381 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Unknown | Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutr NCT00445497 | Clatterbridge Centre for Oncology | Phase 3 |
| Terminated | Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer NCT00486213 | National Cancer Centre, Singapore | Phase 3 |
| Terminated | Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Ce NCT00670605 | Vanderbilt University | — |
| Completed | Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction NCT00499811 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, NCT00458731 | National Cancer Institute (NCI) | Phase 1 |
| Completed | L-Arginine Supplements in Treating Women Who Are Cancer Survivors NCT00459134 | Wake Forest University Health Sciences | N/A |
| Completed | Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy NCT00416624 | Mayo Clinic | Phase 2 |
| Terminated | MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma NCT00504205 | Astex Pharmaceuticals, Inc. | N/A |
| Terminated | Abraxane and Alimta in Advanced Solid Tumors NCT00470548 | University of California, Davis | Phase 1 / Phase 2 |
| Completed | Brief CBT for Anxiety and Advanced Cancer NCT00706290 | Massachusetts General Hospital | Phase 2 |
| Completed | GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors NCT00607724 | Genentech, Inc. | Phase 1 |
| Completed | Stereotactic Radiation Therapy in Treating Patients With Brain Metastases NCT00983359 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | CC-4047 in Treating Patients With Advanced Solid Tumors That Did Not Respond to Treatment NCT00482521 | Case Comprehensive Cancer Center | Phase 1 |
| Completed | Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00471562 | Wake Forest University Health Sciences | Phase 1 |
| Completed | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors NCT00667641 | University of Medicine and Dentistry of New Jersey | Phase 1 |
| Completed | Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors NCT00462553 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagn NCT00638898 | City of Hope Medical Center | Phase 1 |
| Withdrawn | Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases NCT00415376 | Northwestern University | N/A |
| Completed | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors NCT00408655 | National Cancer Institute (NCI) | Phase 1 |
| Completed | PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors NCT00459836 | Proacta, Incorporated | Phase 1 |
| Completed | Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's NCT00443976 | NCIC Clinical Trials Group | Phase 1 |
| Completed | Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors NCT00390000 | Mayo Clinic | Phase 1 |
| Completed | AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma NCT00390117 | NCIC Clinical Trials Group | Phase 1 |
| Terminated | Sorafenib in Treating Patients With Advanced Solid Tumors NCT00436579 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases NCT00424242 | Northwestern University | EARLY_Phase 1 |
| Completed | Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer NCT00112996 | M.D. Anderson Cancer Center | Phase 3 |
| Unknown | Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer NCT00482716 | St. Bartholomew's Hospital | Phase 3 |
| Active Not Recruiting | Assessment Tool for Older Patients With Cancer NCT00477958 | City of Hope Medical Center | N/A |
| Completed | 3-AP in Treating Patients With Advanced or Metastatic Solid Tumors NCT00390052 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors NCT00415324 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Assessing Older Patients With Cancer NCT00416481 | Alliance for Clinical Trials in Oncology | — |
| Completed | Stress Management Therapy in Patients Receiving Chemotherapy for Cancer NCT00377130 | University of South Florida | N/A |
| Completed | Daptomycin in Treating Neutropenia and Fever in Patients With Cancer NCT00335478 | OHSU Knight Cancer Institute | Phase 2 |
| Completed | Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Ca NCT00363129 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors NCT01358227 | Proacta, Incorporated | Phase 1 |
| Completed | Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors NCT00423865 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors NCT00387504 | California Cancer Consortium | Phase 1 |
| Completed | Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer NCT00550927 | Eli Lilly and Company | Phase 1 |
| Completed | Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A in Treating Patients With Advanced Solid Tumors NCT00645060 | City of Hope Medical Center | Phase 1 |
| Completed | Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cance NCT00362986 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Unknown | Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer NCT00544063 | Institut du Cancer de Montpellier - Val d'Aurelle | Phase 1 |
| Completed | S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma NCT00352443 | SWOG Cancer Research Network | Phase 1 |
| Completed | Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors NCT00483366 | University of Nebraska | Phase 1 |
| Completed | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Meta NCT00307255 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Completed | Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors NCT00320073 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Completed | Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung C NCT00408499 | University of California, Davis | Phase 1 / Phase 2 |
| Completed | AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors NCT00372736 | NCIC Clinical Trials Group | Phase 1 |
| Unknown | Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Recept NCT00498992 | Ingalls Memorial Hospital | N/A |
| Completed | AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery NCT00348699 | National Cancer Institute (NCI) | Phase 1 |
| Completed | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in T NCT00536601 | Roswell Park Cancer Institute | N/A |
| Completed | ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer NCT00387608 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in NCT00343460 | Heron Therapeutics | Phase 3 |
| Completed | Bevacizumab and Sunitinib in Treating Patients With Solid Tumors NCT00357318 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | AFP464 in Treating Patients With Advanced Solid Tumors NCT00369200 | National Cancer Institute (NCI) | Phase 1 |
| Completed | 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma NCT00293345 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Cap NCT00296036 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Terminated | PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid NCT00354185 | National Cancer Institute (NCI) | Phase 1 |
| Completed | TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors NCT00356980 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Withdrawn | Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer NCT00899808 | Rutgers, The State University of New Jersey | — |
| Completed | Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers NCT00343629 | Mayo Clinic | N/A |
| Completed | High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer NCT00547547 | City of Hope Medical Center | Phase 1 |
| Completed | An Individualized Internet-Based Health Behavior Program or a Standard Internet-Based Health Behavior Program NCT00128570 | Virginia Polytechnic Institute and State University | N/A |
| Completed | Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors NCT00331955 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors NCT00324480 | National Cancer Institute (NCI) | Phase 1 |
| Completed | PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas NCT00348985 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer NCT00296062 | Case Comprehensive Cancer Center | Phase 1 |
| Terminated | Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors NCT00112684 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | Telemedicine or Standard Care in Treating Patients With Depression and/or Pain Caused By Cancer NCT00313573 | Indiana University Melvin and Bren Simon Cancer Center | Phase 3 |
| Completed | Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgki NCT00275080 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer NCT00661999 | Mayo Clinic | Phase 3 |
| Completed | Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer NCT00514215 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Completed | Spinal Cord Compression. ICORG 05-03, V6 NCT00968643 | Cancer Trials Ireland | Phase 3 |
| Completed | Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men NCT00287833 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Levocarnitine in Treating Fatigue in Cancer Patients NCT00091169 | ECOG-ACRIN Cancer Research Group | Phase 3 |
| Completed | Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Wh NCT00275093 | National Cancer Institute (NCI) | Phase 1 |
| Completed | PR-104 in Treating Patients With Advanced Solid Tumors NCT00349167 | Proacta, Incorporated | Phase 1 |
| Completed | Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors NCT00389922 | University of California, Davis | Phase 1 |
| Completed | Sorafenib and Bortezomib in Treating Patients With Advanced Cancer NCT00303797 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors NCT00622674 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors NCT00305799 | Case Comprehensive Cancer Center | — |
| Completed | Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00243100 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors NCT00559195 | Centre Hospital Regional Universitaire de Limoges | Phase 2 |
| Unknown | AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma NCT00324597 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Completed | AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma NCT00562380 | Amgen | Phase 1 |
| Completed | Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop S NCT00301145 | SRI International | N/A |
| Completed | American Ginseng in Treating Patients With Cancer-Related Fatigue NCT00182780 | Alliance for Clinical Trials in Oncology | N/A |
| Unknown | 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumor NCT00248521 | Institute of Cancer Research, United Kingdom | Phase 1 |
| Completed | Octreotide in Treating Patients With Cancer-Related Malignant Ascites NCT00182754 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00121277 | University Health Network, Toronto | Phase 1 |
| Completed | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer NCT00128622 | H. Kim Lyerly | Phase 1 |
| Completed | Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors NCT00255658 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00126620 | University Health Network, Toronto | Phase 1 |
| Completed | T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors NCT00433407 | Jonsson Comprehensive Cancer Center | N/A |
| Unknown | Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer NCT00274859 | GERCOR - Multidisciplinary Oncology Cooperative Group | Phase 2 |
| Unknown | Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organiza NCT00169312 | Josephine Ford Cancer Center | N/A |
| Completed | Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer NCT00255749 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Completed | Tissue Sample Collection From Patients With Fanconi Anemia NCT00899522 | OHSU Knight Cancer Institute | — |
| Completed | Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors NCT00227513 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Quality of Life of Older Patients Who Are Undergoing Treatment for Cancer and of Their Family Caregivers NCT00255697 | Case Comprehensive Cancer Center | — |
| Completed | Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors NCT00287937 | National Cancer Institute (NCI) | Phase 1 |
| Withdrawn | Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy NCT00296049 | Wake Forest University Health Sciences | N/A |
| Completed | Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressi NCT00138177 | National Cancer Institute (NCI) | Phase 1 |
| Completed | AEG35156 and Docetaxel in Treating Patients With Solid Tumors NCT00357747 | NCIC Clinical Trials Group | Phase 1 |
| Completed | Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors NCT00253344 | Case Comprehensive Cancer Center | Phase 1 |
| Completed | PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases NCT00382252 | Institut Bergonié | N/A |
| Completed | 17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors NCT00119236 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain NCT00666211 | Vanderbilt-Ingram Cancer Center | Phase 3 |
| Completed | Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, NCT00711243 | Northwestern University | Phase 1 / Phase 2 |
| Completed | Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking NCT00245076 | National Cancer Institute (NCI) | N/A |
| Completed | Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma NCT00124605 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid NCT00387322 | University of California, Davis | Phase 1 / Phase 2 |
| Completed | Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer NCT00281853 | Case Comprehensive Cancer Center | — |
| Completed | 17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors NCT00121264 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors NCT00290680 | Medical University of South Carolina | Phase 1 |
| Completed | Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors NCT00276575 | Herbert Hurwitz, MD | Phase 1 |
| Completed | Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors NCT00112476 | National Cancer Institute (NCI) | Phase 1 |